Johnson & Johnson Innovation – JLABS will be organizing a webinar – to be held on September 15, 2021 –
which may be of special interest to entrepreneurs and innovators working in the space of antimicrobial resistance.
The program, “Antimicrobial Resistance – Breakthrough Innovation and Breaking Barriers”, features a panel of global thought leaders who share their views on the challenges surrounding the global health threat of multi-drug resistant bacteria and the potential solutions.
This program is part of BLUE KNIGHT™, a collaboration between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA).
The program includes a former FDA commissioner, representative from CARB-X, individual from the EU Joint Action on AMR and HAI, and a BLUE KNIGHT™ start-up company.
For more details and to register: https://antimicrobial.splashthat.com/community